Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2011

View Archived Issues

Bardoxolone methyl improves renal function in BEAM trial in diabetes-associated kidney disease

Protein epitope mimetic POL-7085 alleviates symptoms of allergic asthma in vivo

Novel antibacterial agents disclosed by Basilea Pharmaceutica

Titan Pharmaceuticals to begin unblinding and data analysis for confirmatory Probuphine trial

Pfizer's phase III Lyrica trial in fibromyalgia meets primary endpoint

BTG acquires U.S. commercial rights to Wellstat Therapeutics' candidate for overexposure to 5-FU

Detailed phase III data on ipilimumab/dacarbazine in metastatic melanoma

GSK presents new selective lysophospholipid S1P1 receptor agonist with promise to treat arthritis

Exemestane prevents breast cancer in at-risk postmenopausal women in NCIC CTG MAP.3 trial

Full pivotal trial data reported on vemurafenib in V600E-mutated B-raf melanoma

New triterpenes for HCV infection patented by Meiji Seika

Actelion synthesizes new formylpeptide receptor modulators

Shionogi & Co. presents novel beta-secretase 1 inhibitors

Relin and MingSight join to develop MS-553 for diabetes-related eye disease

Novartis claims new acetyl-CoA carboxylase 2 inhibitors

Luminex acquires EraGen Biosciences

Novel PI3K inhibitors patented by GSK

Jubilant Discovery Services and Janssen Pharmaceutica enter into drug discovery alliance

Advanced Cell Technology's RPE cells gain E.U. orphan drug status in Stargardt's macular dystrophy

Amgen submits sBLA to expand Xgeva indication to reduce risk of bone metastasis in prostate cancer

NCCN to support phase I trial of Threshold Pharmaceuticals' TH-302 with pazopanib in solid tumors

First-in-human trial of ANAVEX 2-73 for Alzheimer's disease advances

Gentium submits NDA to FDA for defibrotide in treatment of hepatic veno-occlusive disease

Preclinical data show antifibrotic effect of AZX-100 in lung tissue

Pharmasset and Tibotec Pharmaceuticals agree to conduct phase II study of PSI-7977 and TMC-435

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026